Toxic Encephalopathy Acupuncture Point Mapping Atlas

ECCA-TX-ACUPOINT-MAP-0001

Toxic Encephalopathy Acupuncture Point Mapping Atlas

SCF Neural Mapping Schema: Module 1 of Encephalopathy Types

Clinical use classification: Adjunctive supportive neuromodulation only. Toxic encephalopathy requires toxin identification, exposure removal, emergency stabilization, antidote/chelation/dialysis when indicated, and standard medical care.

The SCF neural mapping method follows the layered model: acupoint → peripheral nerve branch → dermatome/myotome → spinal or cranial entry → brainstem/hypothalamic/limbic/cortical node → autonomic, immune, motor, or neurovascular output. Evidence tiers are: A = direct mechanistic/tracing evidence, B = indirect neuroimaging or physiology, C = anatomy-based inference.

I. Toxic Encephalopathy SCF Collapse Targets

ECCA-TX Collapse Node	Therapeutic Mapping Objective
Xenobiotic mitochondrial inhibition	Restore ATP-redox neuroenergetic stability
Oxidative stress	Reduce neuroinflammatory drift
BBB destabilization	Support neurovascular regulation
Glial activation	Modulate neuroimmune hyperexcitability
Autonomic dysregulation	Stabilize vagal/cardiovagal output
Cortical slowing / delirium	Support arousal-connectomic integration
Limbic irritability	Reduce stress-autonomic amplification
GI/toxin clearance burden	Support gut–liver–autonomic axis

II. ECCA-TX Acupoint Neuro-Circuit Atlas

ID	Point	Meridian	Region	Peripheral Nerves	Dermatome	Segment	Central Nodes	Output Circuit	Circuit Network	Evidence
ECCA-TX-01	GV20	Governing Vessel	Vertex scalp	Trigeminal + greater occipital convergence	CN V / C2	Cranial–upper cervical	PFC, limbic system, DMN, autonomic integration nodes	Arousal stabilization, cortical synchronization	Connectomic–limbic–autonomic	B
ECCA-TX-02	GV24	Governing Vessel	Frontal scalp	Supraorbital / supratrochlear branches	CN V1	Cranial	PFC, limbic cortex, hypothalamic interface	Cognitive arousal, frontal executive stabilization	Frontal–limbic	C
ECCA-TX-03	Yintang	Extra point	Glabellar region	Supratrochlear / infratrochlear branches	CN V1	Cranial	Limbic cortex, hypothalamus, autonomic nuclei	Anxiety–delirium calming, autonomic downshift	Limbic–autonomic	C
ECCA-TX-04	GV26	Governing Vessel	Philtrum / upper lip	Infraorbital branch, facial sensory interface	CN V2	Cranial	Brainstem arousal networks, trigeminal nucleus	Acute arousal support, sensorimotor activation	Brainstem–arousal	C
ECCA-TX-05	GB20	Gallbladder	Suboccipital neck	Greater occipital / suboccipital nerves	C2–C3	Upper cervical	Brainstem, vestibular nuclei, cerebellar interface	Headache, vertigo, autonomic stabilization	Cervico-brainstem	C
ECCA-TX-06	BL10	Bladder	Upper posterior neck	Greater occipital / cervical dorsal rami	C2–C3	Upper cervical	Cervical dorsal horn, brainstem autonomic nodes	Cervical–autonomic regulation	Cervico-autonomic	C
ECCA-TX-07	LI4	Large Intestine	Dorsal hand	Superficial radial / median territory	C6–C7	Cervical	Thalamus, insula, ACC, PAG, limbic pain network	Descending analgesia, craniofacial modulation	Nociceptive–limbic	B
ECCA-TX-08	LI11	Large Intestine	Lateral elbow	Radial nerve territory	C5–C6	Cervical	Hypothalamus, PAG	Anti-inflammatory modulation	Neuroimmune	B
ECCA-TX-09	PC6	Pericardium	Volar forearm	Median nerve	C6–T1	Cervical–thoracic	PVN, brainstem autonomic nuclei	Cardiovagal regulation, nausea/autonomic control	Cardiovagal–autonomic	A/B
ECCA-TX-10	PC5	Pericardium	Volar forearm	Median nerve	C6–T1	Cervical–thoracic	PVN, brainstem autonomic nuclei	Cardiopulmonary reflex modulation	Cardiovagal–autonomic	A/B
ECCA-TX-11	HT7	Heart	Ulnar wrist	Ulnar nerve territory	C8–T1	Cervical–thoracic	Limbic-autonomic networks	Sleep, anxiety, autonomic stabilization	Limbic–autonomic	B
ECCA-TX-12	ST36	Stomach	Anterolateral leg	Deep peroneal / common fibular-tibial fascia zone	L4–L6 equivalent animal; human lower-limb segmental mapping	Lumbosacral → brainstem	NTS, DMV, adrenal output pathways	Vagal-adrenal anti-inflammatory reflex	Neuroimmune–metabolic	A
ECCA-TX-13	ST40	Stomach	Lateral leg	Superficial/deep peroneal region	L5	Lumbosacral	Brainstem, limbic-autonomic nodes	Phlegm/metabolic neuroregulation; cognitive clouding support	Metabolic–autonomic	C
ECCA-TX-14	SP6	Spleen	Medial lower leg	Tibial nerve territory	L4–S2	Lumbosacral	Hypothalamic-autonomic-endocrine networks	Pelvic-visceral, endocrine-autonomic regulation	Endocrine–autonomic	B/C
ECCA-TX-15	LV3	Liver	Dorsal foot	Deep peroneal / tibial foot region	L5–S1	Lumbosacral	Pain-limbic-autonomic networks	Stress-pain-autonomic modulation	Limbic–autonomic	B/C
ECCA-TX-16	KI3	Kidney	Medial ankle	Tibial nerve / saphenous overlap	L4–S1	Lumbosacral	Spinal-autonomic, hypothalamic interface	Fluid–endocrine-autonomic support	Renal–autonomic	C
ECCA-TX-17	ST25	Stomach	Abdomen	Intercostal abdominal somatic afferents	T10–T11	Thoracic	Spinal sympathetic circuits	Gut modulation, sympatho-visceral regulation	Autonomic–visceral	A
ECCA-TX-18	CV12	Conception Vessel	Epigastrium	Intercostal / anterior cutaneous branches	T7–T9	Thoracic	Brainstem visceral nuclei, hypothalamus	Gastric regulation, nausea support	Visceral–autonomic	C
ECCA-TX-19	CV17	Conception Vessel	Sternum	Intercostal anterior cutaneous branches	T2–T5	Thoracic	Brainstem cardiopulmonary nodes	Respiratory-cardiovagal settling	Cardiopulmonary–autonomic	C
ECCA-TX-20	BL18	Bladder	Back-shu liver region	Thoracic dorsal rami	T7–T9	Thoracic	Spinal sympathetic, hypothalamic visceral networks	Hepatic-autonomic regulation	Hepatic–visceral	C
ECCA-TX-21	BL20	Bladder	Back-shu spleen region	Thoracic dorsal rami	T9–T11	Thoracic	Spinal sympathetic, gut-brain interface	Metabolic-visceral stabilization	Gut–immune–autonomic	C
ECCA-TX-22	BL23	Bladder	Lumbar kidney region	Lumbar dorsal rami	L1–L3	Lumbar	Spinal autonomic, hypothalamic interface	Renal-fluid-autonomic support	Renal–autonomic	C
ECCA-TX-23	BL40	Bladder	Popliteal fossa	Tibial / common fibular region	L5–S2	Lumbosacral	Spinal segmental pain circuits	Lumbosacral pain inhibition, motor support	Sensorimotor–nociceptive	B/C
ECCA-TX-24	GB34	Gallbladder	Lateral leg	Common peroneal region	L4–S1	Lumbosacral	Sensorimotor, basal ganglia, pain networks	Motor coordination, musculoskeletal recovery	Sensorimotor–basal ganglia	B/C

III. Primary Therapeutic Circuit Stack for Toxic Encephalopathy

SCF Role	Point Cluster	Primary Objective
Connectomic Stabilizers	GV20, GV24, Yintang, GV26	Arousal, cognition, delirium-pattern stabilization
Neuroimmune Modulators	ST36, LI11, LI4	Cytokine drift, glial activation, pain/inflammation coupling
Autonomic Regulators	PC6, PC5, HT7, CV17	Cardiovagal balance, nausea, anxiety, respiratory-autonomic control
Gut–Liver–Toxin Axis	ST25, CV12, BL18, BL20	Visceral-autonomic support during detoxification burden
Renal–Fluid Axis	KI3, BL23	Supportive renal-autonomic mapping, not a substitute for toxin clearance therapy
Sensorimotor Recovery	GB34, BL40, GB20, BL10	Vertigo, weakness, motor instability, cervico-brainstem regulation

IV. Evidence-Controlled Interpretation

High-confidence anchors include ST36, ST25, and PC5–PC6, with ST36 linked to vagal-adrenal anti-inflammatory signaling, ST25 to spinal sympathetic gut modulation, and PC5–PC6 to median-afferent cardiopulmonary reflex circuitry. Moderate anchors include LI4, GV20, HT7, LV3, SP6, GB34, and BL40, which the SCF mapping model identifies as neuroimaging/physiology-supported or convergent evidence points. Remaining toxic-encephalopathy rows are atlas-level anatomical inferences based on nerve territory, dermatome, tissue depth, and likely circuit family, consistent with the SCF full-atlas construction rule.

V. Clinical Deployment Logic

Clinical State	SCF Mapping Priority	Candidate Point Emphasis
Acute confusion / delirium	Arousal-connectomic stabilization	GV20, GV24, GV26, Yintang
Nausea / autonomic instability	Cardiovagal regulation	PC6, PC5, CV17
Neuroinflammatory drift	Anti-inflammatory neuromodulation	ST36, LI11, LI4
GI toxin burden	Gut–brain–visceral regulation	ST25, CV12, BL20
Hepatic toxic load	Liver-visceral autonomic support	BL18, LV3
Weakness / motor slowing	Sensorimotor circuit support	GB34, BL40
Sleep disruption / agitation	Limbic-autonomic calming	HT7, Yintang, GV20

VI. Safety and Exclusion Notes

This atlas is not a standalone treatment protocol. In suspected toxic encephalopathy, urgent clinical priorities are exposure cessation, airway/breathing/circulation stabilization, toxin identification, poison-control consultation, antidote or chelation when indicated, seizure management, renal/hepatic support, and ICU-level care when needed. Acupuncture mapping may be considered only as adjunctive supportive care after medical stabilization and contraindication screening.

MASTER DOCUMENT REGISTRY INDEX

SCF-ECCA-TX-ACU-0001 — Toxic Encephalopathy Acupoint Neuro-Circuit Mapping Atlas
SCF-ECCA-0001 — Encephalopathy Connectomic Collapse Atlas
SCF-ACU-NEURO-ATLAS-0001-M1 — SCF Acupoint Neuro-Circuit Atlas Module 1
SCF-361-POINT-NEURAL-MAPPING-0002 — SCF Neural Mapping Schema
SCF-PATH-PROT-0001 — SCF Pathophysiology Protocol